fda warning letters compounded glp-1 september 2025 Semaglutide & Tirzepatide 2025: Safe Use Guide FDA issues 30 warning letters

Potential Mechanisms Several mechanisms may explain the association: Weight reduction leading to improved lung mechanics Reduced systemic inflammation Possible direct immunomodulatory effects of GLP-1 signaling However, the observational design means causality cannot be established

Among employers covering GLP-1 agonist drugs for weight loss, most firms view it as important or very important for employee satisfaction The meaningful shares of larger employers covering these medications for weight loss, notwithstanding their relatively high cost, underscores the importance many employers place on covering these medications for employees

In at least six states, lawmakers ultimately walked away after closer review

Its unclear whether these changes stem from direct neurological effects or are byproducts of other health improvements

[DOI] [PMC free article] [PubMed] [Google Scholar] 95.Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, et al